A status conference was held Friday before U.S. District Judge John R. Tunheim, who is overseeing the federal Levaquin lawsuits pending in Minnesota. In documents filed with the Court before the conference, the attorneys for the parties disagreed about the process the court should adopt for selecting the first cases for trial. Continued
All Posts Tagged With: "Antibiotic"
First MDL Levaquin Tendon Rupture Lawsuits Could be “Trial-Ready” by Jan 2010
A status conference was held earlier this month before U.S. District Judge John R. Tunheim, who is overseeing the federal Levaquin litigation consolidated in Minnesota. At that time, lawyers for Johnson & Johnson and lawyers for plaintiffs who have filed Levaquin lawsuits alleging tendon damage caused by the popular antibiotic, indicated that they expect the first MDL cases to be “trial-ready” by January 2010. Continued
Maxipime Lawsuits
Maxipime is an injectable antibiotic which is used for treatment of serious infections, such as pneumonia. Recent studies have raised concerns about an increased risk of death found among individuals treated with the antibiotic. Continued
FDA is Continuing to Review Safety Concerns About Maxipime (cefepime) Death Risk
On Wednesday, the FDA provided an update to an early communication issued last November about concerns that an injectable antibiotic known as Maxipime (cefepime), may increase the risk of death when compared to similar drugs. Although the FDA originally indicated that the preliminary review would take about four months, they have indicated that the review of safety data is still ongoing. Continued
